Abstract
Abstract
Objective
To review the literature on intratympanic gentamicin treatment as prehabilitation for patients undergoing surgery for a unilateral vestibular schwannoma.
Data sources
A systematic literature search was conducted up to March 2023 in Pubmed, Embase, Cochrane, Web of Science, Academic Search Premier, Google Scholar and Emcare databases.
Review methods
Articles on the effect of intratympanic gentamicin followed by vestibular schwannoma surgery were reviewed. Data on objective vestibular function and subjective outcomes were compiled in tables for analysis. Relevance and methodological quality were assessed with the methodological index for non-randomized tool.
Results
A total of 281 articles were identified. After screening and exclusion of duplicates, 13 studies were reviewed for eligibility, of which 4 studies could be included in the review. The posturography test, the subjective visual horizontal test, and the optokinetic nystagmus test showed decreased vestibular function in the group of patients who received intratympanic gentamicin before microsurgery compared to the group of patients without gentamicin. Other objective tests did not show significant differences between patient groups. Subjective vestibular outcomes, as evaluated by questionnaires on quality of life and/or dizziness, did not seem to improve from intratympanic gentamicin pretreatment.
Conclusion
Vestibular schwannoma patients who received intratympanic gentamicin before surgical resection of the tumor performed better in the posturography test, subjective visual horizontal test, and the optokinetic nystagmus test afterwards. However, studies that also evaluated subjective outcomes such as dizziness, anxiety, depression, and balance self-confidence did not show a positive effect of intratympanic gentamicin on the vestibular complaints and symptoms.
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Otorhinolaryngology
Reference20 articles.
1. Carlson ML, Tveiten OV, Driscoll CL, Goplen FK, Neff BA, Pollock BE, Tombers NM, Lund-Johansen M, Link MJ (2015) What drives quality of life in patients with sporadic vestibular schwannoma? Laryngoscope 125(1697):1702
2. Fuentealba-Bassaletti C, Neve OM, van Esch BF, Jansen JC, Koot RW, van Benthem PPG, Hensen EF (2023) Vestibular complaints impact on the long-term quality of life of vestibular schwannoma patients. Otol Neurotol. 44(2):161–167. https://doi.org/10.1097/MAO.0000000000003773
3. Tjernström F, Fransson PA, Kahlon B, Karlberg M, Lindberg S, Siesjö P, Magnusson M (2009) Vestibular PREHAB and gentamicin before schwannoma surgery may improve long-term postural function. J Neurol Neurosurg Psychiatry 80(1254):1260. https://doi.org/10.1136/jnnp.2008.170878
4. Schuknecht HF (1957) Ablation Therapy in the Management of Ménière’s Disease. Acta Otolaryngol 47(132):5–42. https://doi.org/10.3109/00016485709125788
5. Lanvers-Kaminsky C, Zehnhoff-Dinnesen AG, Parfitt R, Ciarimboli G (2016) Drug-induced ototoxicity: mechanisms, pharmacogenetics, and protective strategies. Clin Pharmacol Ther. 101(4):491–500. https://doi.org/10.10002/cpt.603
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献